Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
Shortfall Despite of Revenues elevation at in the April to June 30 2022 span
company recorded second quarter of 2022 operating loss of $-1.3 millions
Published Aug 21 2022
CSIMarket Team / CSIMarket.com
Revenue grew barely by 2.017 % to $15.28 millions from $14.98 millions in the comparable reporting period a year ago and sequentially Revenues improved by 17.887 % from $12.96 millions.
For the April to June 30 2022 span Xtant Medical Holdings Inc realized net deficit of $-1.710 million, larger than $-0.733 million a year ago.
Xtant Medical Holdings Inc is expected to report next financial results on May 04, 2023.
Other XTNT's news
Xtant Medical Fortifies Financial Foundation with $17 Million Revolving Credit Facility Expansion
Compelling period by the Xtant Medical Holdings Inc all along the most recent fiscal period
Robust 32.434% Top-line rise at XTNT over the financial second quarter of 2023
The Diminishing Returns have widen more at the amid the financial span closing September 30 2022
Shortfall Despite of Revenues elevation at in the April to June 30 2022 span
Loss larger than a year ago but Topline was Up moderately at in the financial first quarter of 2022
Other XTNT's news
Xtant Medical Fortifies Financial Foundation with $17 Million Revolving Credit Facility Expansion
Compelling period by the Xtant Medical Holdings Inc all along the most recent fiscal period
Robust 32.434% Top-line rise at XTNT over the financial second quarter of 2023
The Diminishing Returns have widen more at the amid the financial span closing September 30 2022
Shortfall Despite of Revenues elevation at in the April to June 30 2022 span
Loss larger than a year ago but Topline was Up moderately at in the financial first quarter of 2022